What are the treatment guidelines for scrub typhus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Guidelines for Scrub Typhus

Doxycycline is the first-line treatment for scrub typhus in most patients, with azithromycin as an effective alternative particularly in pregnant women and children. 1, 2, 3

First-Line Treatment Options

Adults and Children >8 Years:

  • Doxycycline:
    • Dosage: 100 mg twice daily for 7-14 days
    • FDA-approved for rickettsial infections including scrub typhus 1
    • Fastest time to defervescence compared to alternatives 4

Special Populations:

  • Pregnant women and children <8 years:
    • Azithromycin: 500 mg on day 1, then 250 mg daily for 4 days (adults)
    • Pediatric dose: 10 mg/kg on day 1, then 5 mg/kg for 4 days
    • Safe in pregnancy with favorable outcomes 2

Alternative Treatment Options

  • Minocycline: Shown to be more effective than azithromycin in northern China, with shorter time to defervescence 4
  • Chloramphenicol: 500 mg four times daily for 7-14 days
  • Rifampicin: Effective in areas with documented doxycycline resistance 5

Treatment Considerations

Efficacy and Response

  • Most patients defervescence within 48-72 hours after initiating appropriate therapy
  • Treatment failure is rare with appropriate antibiotic selection
  • Complete the full course of antibiotics to prevent relapse

Resistance Concerns

  • Doxycycline resistance has been reported in northern Thailand, but is considered controversial and may be a misconception 6
  • In areas with suspected resistance, consider azithromycin or rifampicin as alternatives 5

Monitoring and Follow-up

  • Monitor for clinical improvement within 48-72 hours of treatment initiation
  • If no improvement occurs within this timeframe, consider:
    1. Alternative diagnosis
    2. Potential resistance (especially in northern Thailand)
    3. Switching to an alternative antibiotic

Comparative Effectiveness

A meta-analysis of treatment options showed:

  • Azithromycin has comparable treatment success rates to doxycycline 3
  • Azithromycin has fewer adverse effects than doxycycline 3
  • Doxycycline achieves faster fever clearance (approximately 4.4 hours faster) 3

Common Pitfalls and Caveats

  • Delayed treatment: Early initiation of appropriate antibiotics is crucial to prevent complications
  • Inadequate duration: Complete the full course of antibiotics (7-14 days)
  • Misdiagnosis: Consider scrub typhus in patients with acute febrile illness, headache, myalgia, and eschar in endemic areas
  • Resistance misconception: True doxycycline resistance is rare; treatment failures may be due to other factors 6

Treatment Algorithm

  1. Initial assessment:

    • Evaluate for severity indicators (respiratory distress, altered mental status, shock)
    • Check for pregnancy status and age
  2. Treatment selection:

    • Non-pregnant adults and children >8 years: Doxycycline
    • Pregnant women and children <8 years: Azithromycin
    • Severe disease: Consider IV formulations initially
  3. Monitoring response:

    • Expect defervescence within 48-72 hours
    • If no improvement, reassess diagnosis or consider alternative antibiotic
  4. Complete treatment course:

    • Continue antibiotics for full 7-14 days regardless of clinical improvement

Scrub typhus remains an important health threat in endemic areas, but with appropriate and timely antibiotic therapy, most patients recover completely without complications.

References

Research

Scrub typhus.

Indian journal of anaesthesia, 2013

Research

Drug treatment of scrub typhus.

Tropical doctor, 2011

Research

Scrub Typhus and the Misconception of Doxycycline Resistance.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.